Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

The Caenorhabditis elegans Elongator complex regulates neuronal alpha-tubulin acetylation.

Jachen A Solinger | Roberta Paolinelli | Holger Klöss | Francesco Berlanda Scorza | Stefano Marchesi | Ursula Sauder | Dai Mitsushima | Fabrizio Capuani | Stephen R Stürzenbaum | Giuseppe Cassata
PLoS genetics | 2010

Although acetylated alpha-tubulin is known to be a marker of stable microtubules in neurons, precise factors that regulate alpha-tubulin acetylation are, to date, largely unknown. Therefore, a genetic screen was employed in the nematode Caenorhabditis elegans that identified the Elongator complex as a possible regulator of alpha-tubulin acetylation. Detailed characterization of mutant animals revealed that the acetyltransferase activity of the Elongator is indeed required for correct acetylation of microtubules and for neuronal development. Moreover, the velocity of vesicles on microtubules was affected by mutations in Elongator. Elongator mutants also displayed defects in neurotransmitter levels. Furthermore, acetylation of alpha-tubulin was shown to act as a novel signal for the fine-tuning of microtubules dynamics by modulating alpha-tubulin turnover, which in turn affected neuronal shape. Given that mutations in the acetyltransferase subunit of the Elongator (Elp3) and in a scaffold subunit (Elp1) have previously been linked to human neurodegenerative diseases, namely Amyotrophic Lateral Sclerosis and Familial Dysautonomia respectively highlights the importance of this work and offers new insights to understand their etiology.

Pubmed ID: 20107598

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: Telethon, Italy
    Id: GGP08119

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Swiss National Science Foundation (tool)

RRID:SCR_011554

The Swiss National Science Foundation (SNSF) is Switzerland''s leading provider of scientific research funding. The SNSF annually supports some 7200 researchers, almost 80 percent of whom are aged 35 years or younger. With its federal mandate, it supports basic research in all disciplines, from philosophy and biology to the nanosciences and medicine. It also invests in applied research in various scientific fields. The focus of its activities is the scientific endorsement of projects submitted by researchers. The best applicants are funded by the SNSF with an annual total amount equalling approximately CHF 700 million. Established in 1952 as a foundation under private law, the SNSF has the autonomy it needs to promote independent scientific research. The SNSF is committed to promoting young scientists and works to ensure that scientific research in Switzerland has the most favourable conditions for developing internationally. It also encourages dialogue between scientists and representatives in society, politics and the economy.

View all literature mentions

Torrey Pines Biolabs (tool)

RRID:SCR_003580

An Antibody supplier

View all literature mentions